Tissue Scaffolds Market by Product, Application, and Geography - Forecast and Analysis 2021-2025

The tissue scaffolds market share is expected to increase by USD 1.20 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 11%.

The market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by product (natural tissue scaffolds and synthetic tissue scaffolds), geography (North America, Europe, Asia, and ROW), and Application (musculoskeletal, dermatological, cardiovascular, and other applications).

The tissue scaffolds market report also offers information on several market vendors, including Integra LifeSciences Holdings Corp., Medtronic Plc, Merck KGaA, MiMedx Group Inc., Nuvasive Inc., Organogenesis Inc., RTI Surgical Holdings Inc., Smith & Nephew plc, Stryker Corp., and Thermo Fisher Scientific Inc. among others.

Nuvasive Inc. - The company offers tissue scaffolds such as Osteocel Plus, Osteocel Pro, and Attrax Scaffold. Under the unified business segment, the company generates revenue from a single operating segment which includes the development of spinal hardware and surgical support products.

What will the Tissue Scaffolds Market Size be During the Forecast Period?

Get the Tissue Scaffolds Market Size Forecast by Downloading the Report Sample

Parent Market Analysis

Technavio categorizes the global tissue scaffolds market as a part of the global healthcare equipment market. Our research report extensively covers external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the tissue scaffolds market during the forecast period.

Tissue Scaffolds Market: Key Drivers, Trends, and Challenges

Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Tissue Scaffolds Market Driver

• One of the key factors driving growth in the tissue scaffolds market is the increasing prevalence of chronic and acute wounds.
• Globally, the prevalence of acute wounds such as surgical and traumatic wounds (abrasion, puncture, laceration, and incision) and chronic wounds such as venous ulcers, diabetic ulcers, and pressure ulcers is increasing.
• The prevalence of cardiovascular diseases (CVDs) such as angina, stroke, heart failure, venous thromboembolism, and heart arrhythmia is also increasing. CVDs caused approximately 19 million deaths globally in 2020. Individuals affected by these diseases are increasingly adopting tissue engineering methods for their treatment. This is increasing the adoption of tissue scaffolds, which, in turn, is driving the global tissue scaffolds market. 

Key Tissue Scaffolds Market Challenge

• The shortage of tissue donors will be a major challenge for the tissue scaffolds market during the forecast period.
• There is a global shortage of tissue donors, which is significantly restricting the growth of the global tissue scaffolds market. In addition, due to seasonal changes in mortality rates, some scarce tissues that are used for allografts are, at times, in short supply.
• The availability of donated tissues is also significantly being impacted by regulatory actions in the industry, public opinion of the donor process, and the company's reputation in the market.
• Many vendors also face supply constraints for tissue scaffolds in terms of limited control over the availability, quality, and delivery schedules. Hence, the limited availability of tissue donors is restricting the growth of the global tissue scaffolds market.

This tissue scaffolds market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Tissue Scaffolds Market Value Chain Analysis

Our In-house experts produce extensive information on the value chain and parent market of the tissue scaffolds market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies. The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.

Which are the Key Regions for Tissue Scaffolds Market?

Get a glance at the market share of various regions by Requesting a PDF Sample now!

41% of the market’s growth will originate from North America during the forecast period. The US is the key market for tissue scaffolds in North America. Market growth in this region will be faster than the growth of the market in ROW regions.

North America is the major revenue contributor to the global tissue scaffolds market. The strong market presence of key vendors such as Smith & Nephew Plc (Smith & Nephew), RTI Surgical Inc. (RTI Surgical), and Integra LifeSciences Holdings Corp. (Integra Lifesciences) contributes to the high revenue of this region. Vendors are launching new products and reorganizing sales forces to increase their market penetration in North America. This will facilitate the tissue scaffold market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What is the Fastest-Growing Product Segment in the Tissue Scaffolds Market?

To gain insights on the market contribution of various segments Request a PDF Sample

The tissue scaffolds market share growth by the natural tissue scaffolds segment will be significant during the forecast period. End-users are increasingly adopting natural biomaterials as they are found in abundance in replenishable agricultural food resources and provide enhanced biodegradability and biocompatibility. However, they have limited physical and mechanical stability. Hence, they may not be suitable for load-bearing applications. Some major vendors offering natural tissue scaffolds are Organogenesis, Integra LifeSciences, and MiMedx Group. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the tissue scaffolds market size and actionable market insights on the post-COVID-19 impact on each segment.

Request PDF sample

What are the Key Data Covered in this Tissue Scaffolds Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive tissue scaffolds market growth during the next five years
• Precise estimation of the tissue scaffolds market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behaviour
• The growth of the tissue scaffolds market industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive analysis of factors that will challenge the growth of tissue scaffolds market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch